For more than a decade, a class of drugs called BET inhibitors has been tested in cancer trials with high expectations. The ...

Researchers at the University of Bayreuth have, for the first time, deciphered key steps in the biosynthetic mechanism of the ...

Opportunities in the anti-cancer mAbs market include growth in personalized cancer medicine, expansion of biosimilar mAbs, ...

Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies to treat cancer. Dr. Jesse Armitage, from The University of Western ...

A message of support and collective responsibility was delivered on April 2, 2026 by representatives of the state, political and ecclesiastical leadership, who attended the street-side fundraising ...

Even every day staples can pack health benefits more powerful than fancy superfoods or supplements. Dr Rajan shares the ...